"" We do not expect their technology to be cost competitive in the US.""
If Befesa have 60% of the European market , and are profitable , why would they not be cost competitive in the US??
Interesting point (and reply) about the Befesa patent. No such protection for MHM?
I agree Bens replies seem highly defensive and raise more questions than answers but I would suggest , due to ongoing delays at Geelong and in the USA he simply cannot say more at this point.
Good work bcompton , thumbs up.
DYOR
"" We do not expect their technology to be cost competitive in...
Add VYS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.4M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.0¢ | $28.80K | 101.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35000 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.37pm 04/07/2024 (20 minute delay) ? |
| VYS (ASX) Chart |